Michaelson Jennifer

Chief Scientific OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Feb 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$165K
Net Open-Market Flow
-$165K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Sell(S)8K$14.30$114K182K
Feb 20, 2026Option exercise(M)8K$4.30$34K190K
Feb 20, 2026Sell(S)4K$13.62$51K182K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)8K$0125K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-064256) within minutes of acceptance. Every field above traces to the original document. Verify it directly: